NCT07635147 Decision Support Tool for Patients With Advanced Breast Cancer
| NCT ID | NCT07635147 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Breast Cancer Metastatic |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-06-17 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-06-17 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pilot study is to understand and improve the shared decision-making process between people with advanced breast cancer and their providers regarding their care and treatment. As part of this study, the researchers will evaluate a decision support tool called COAST that was designed to support patients and providers in having meaningful conversations. The main questions it aims to answer are: 1. Can the COAST tool improve the quality of communication between patients and their oncology providers? 2. Is the COAST tool acceptable, appropriate, and easy to use at NYP-Weill Cornell Medicine, NYP-Brooklyn Methodist Hospital and NYP-Queens? Participants will be asked to fill out two surveys: one before they use the COAST tool and another about 2 - 4 weeks later. Some patients will also be invited for an interview.
Eligibility Criteria
Inclusion Criteria: * Male or female 18 years and older * Diagnosis of Stage IV breast cancer * English, Spanish or Mandarin speaking Exclusion Criteria: * Early breast cancer * Individuals speaking languages other than English, Spanish, or Mandarin as their primary language
Contact & Investigator
Shoshana Rosenberg, ScD, MPH
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT07635147 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Cancer Metastatic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07635147 currently recruiting?
Yes, NCT07635147 is actively recruiting participants. Contact the research team at zkh4001@med.cornell.edu for enrollment information.
Where is the NCT07635147 trial being conducted?
This trial is being conducted at Brooklyn, United States, Flushing, United States, New York, United States.
Who is sponsoring the NCT07635147 clinical trial?
NCT07635147 is sponsored by Weill Medical College of Cornell University. The principal investigator is Shoshana Rosenberg, ScD, MPH at Weill Medical College of Cornell University. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.